A guiding patch structure for sunlight exposure duration

A guiding patch structure detects tachysterol formation to provide real-time, personalized sunlight exposure guidance, addressing vitamin D synthesis issues and preventing deficiency or damage.

WO2026235643A1PCT designated stage Publication Date: 2026-11-12AKPOLAT NEBAHAT DEMET
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
PCT/TR2025/050466
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-05-08
Publication Date
2026-11-12

AI Technical Summary

Technical Problem

Existing products fail to provide real-time feedback and personalized guidance on safe sunlight exposure duration for vitamin D synthesis, leading to potential vitamin D deficiency or harmful skin damage due to insufficient or excessive sun exposure.

Method used

A single-use guiding patch structure impregnated with a biomarker that detects tachysterol formation in the skin, changing color to indicate optimal vitamin D synthesis, thereby informing users to adjust sun protection methods.

Benefits of technology

Enables real-time, personalized guidance for safe sunlight exposure duration, minimizing vitamin D deficiency and skin damage by detecting tachysterol levels using chromatography techniques.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to a single-use guiding patch structure for sunlight exposure duration, which determines that a sufficient amount of vitamin D has been synthesised in the skin by measuring precursors or vitamin D levels at the molecular level in human skin, informs the user of the optimal duration of sun exposure by changing colour upon reaching the appropriate level, and thereby minimises vitamin D deficiency or harmful skin damage that may result from insufficient or excessive sun exposure.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] A GUIDING PATCH STRUCTURE FOR SUNLIGHT EXPOSURE DURATION

[0002] Technical Field:

[0003] The invention relates to a single-use guiding patch structure for sunlight exposure duration, which determines that a sufficient amount of vitamin D has been synthesised in the skin by measuring precursors or vitamin D levels at the molecular level in human skin, informs the user of the optimal duration of sun exposure by changing colour upon reaching the appropriate level, and thereby minimises vitamin D deficiency or harmful skin damage that may result from insufficient or excessive sun exposure.

[0004] State of the Art

[0005] Nowadays, many individuals benefit from sunlight to address vitamin D deficiency. However, insufficient or excessive sun exposure can lead to problems such as vitamin D deficiency or harmful skin damage, including sunburn or skin cancer.

[0006] Vitamin D is, in fact, a fat-soluble prohormone steroid with endocrine, paracrine, and autocrine functions. Its primary role is to regulate calcium levels in the bloodstream by continuously permitting calcium and phosphate absorption from the intestines, or by mobilising calcium from the bones. Additionally, when present at optimal concentrations, vitamin D acts as a supportive agent that does not, on its own, exert a detectable effect on calcium absorption, but allows or facilitates a flexible physiological response to varying calcium requirements.

[0007] The paracrine and autocrine effects of vitamin D depend on gene transcription specific to cell types that express nuclear vitamin D receptors. These potential effects include inhibition of cell proliferation, promotion of cell differentiation, and apoptosis, which may play roles in cancer, immunity, and various organ systems.

[0008] Under exposure to sunlight or UVB irradiation (with a peak effective wavelength range of 280-320 nm), 7-dehydrocholesterol in the skin is converted to pre-D3. Precursor 7-dehydrocholesterol in the plasma membranes of both basal and suprabasal keratinocytes and dermal fibroblasts is transformed into previtamin D3. Vitamin D3 synthesised in the skin is released from the plasma membrane and enters systemic circulation bound to vitamin D-binding protein (DBP). Serum concentrations of vitamin D3 peak 24-48 hours after UV radiation exposure. Thereafter, vitamin D3 levels decrease exponentially, with a serum half-life ranging between 36 and 78 hours.

[0009] Continued UV exposure also leads to the conversion of pre-D3 into inactive metabolites known as lumisterol and tachysterol. Both the degree of epidermal pigmentation and the intensity of exposure are associated with the time required to reach the maximum concentration of pre-D3; however, they do not alter the maximum level achieved. Even though the level of pre-D3 in the skin reaches its peak, the biologically inactive lumisterol continues to accumulate under prolonged UV exposure. Tachysterol is also formed, but unlike pre-D3, it does not accumulate with extended UV exposure. The formation of lumisterol is reversible and may be reconverted into pre-D3 as pre-D3 levels decrease (at 0°C, D3 is not formed; however, at 37°C, pre-D3 is rapidly converted into D3).

[0010] Tachysterol, which is structurally similar to vitamin D, exhibits a rotated A-ring by 180 degrees and a shift in the triene region, thereby facilitating the positioning of double bonds within both the A and C rings. Despite this structural similarity, tachysterol exhibits minimal chemical reactivity and possesses a significant extinction coefficient. As a result, its physiological role is assumed to be the prevention of excessive previtamin D formation caused by excessive UV exposure. Tachysterol shows a higher level of photoproduct formation compared to vitamin D and thus serves as a primary alternative degradation pathway for vitamin D.

[0011] The effective spectral range of UV radiation required for synthesising vitamin D in the skin is defined as the action spectrum covering 255-330 nm (with a peak effect around 295 nm within the UVB range). Although there is no standardisation regarding the duration of UV exposure required to synthesise sufficient vitamin D in the skin, various parameters — such as the angle of sunlight incidence, time of day, season, cloudiness or rainfall, the individual’s Fitzpatrick skin type, and the exposed body surface area — influence this duration. Exposure of the entire body to UVB radiation that induces thelight pink colour of the minimal erythema dose for approximately 15-20 minutes can stimulate the production of up to 250 pg of vitamin D (10,000 III).

[0012] As a fat-soluble molecule, vitamin D3 can be taken up by adipocytes and stored in subcutaneous or omental fat for later use.

[0013] Once it enters circulation, vitamin D is converted by a hepatic hydroxylase into 25-hydroxyvitamin D (25(OH)D; calcidiol). The circulating level of 25(OH)D is an indicator of vitamin D status. This level reflects both ultraviolet exposure and dietary vitamin D intake. The serum half-life of 25(OH)D is approximately 15 days. 25(OH)D is not biologically active except at very high, non-physiological levels. When needed, 25(OH)D is converted in the kidney into its active hormonal form, 1,25-dihydroxyvitamin D (1 ,25(OH)DD; calcitriol), a process that is generally tightly regulated by parathyroid hormone.

[0014] It is important to note that the conversion of previtamin D3 into its inactive photoproducts, lumisterol and tachysterol, functions as a feedback loop that regulates the cutaneous biosynthesis of vitamin D3. This mechanism ensures that an individual cannot become “overdosed” on vitamin D3 through sunlight exposure alone. After exposure to minimal erythema dose that is less than I (MED — i.e., the amount of photonic exposure required to produce slight pinkness in the skin 24 hours postexposure), the concentration of previtamin D3 reaches its maximum level, and further UV radiation results only in the production of inactive metabolites.

[0015] Although vitamin D has essential properties due to its endocrine, autocrine, and paracrine effects, its synthesis requires exposure to UV radiation. Vitamin D deficiency may lead to osteoporotic fractures, immune disorders, rickets, various inflammatory diseases, and cancers; however, excessive UV exposure for the purpose of vitamin D synthesis also carries the risk of causing skin cancers and malignant melanoma. The numerous potential effects of vitamin D on human health and disease have led to increased interest in addressing vitamin D deficiency and in identifying the best methods for normalising suboptimal levels.

[0016] However, the products and applications found in the state of the art either fail to provide real-time feedback or offer the same general recommendations to all users, without sufficiently taking into account factors such as the user's geographical location, currentUV level, skin type, or exposure duration. These shortcomings make it difficult for individuals to remain within safe limits while also obtaining an optimal level of vitamin D.

[0017] The deficiencies and problems encountered in the products and applications in the state of the art have made it necessary to develop a guiding patch structure for sunlight exposure duration for the user.

[0018] The Aim of the Invention

[0019] The invention aims to determine whether a sufficient amount of vitamin D has been synthesised in the skin by performing a molecular-level measurement of precursors or vitamin D levels in human skin, and to inform and guide the user accordingly.

[0020] In this way, the invention aims to minimise vitamin D deficiency or harmful skin damage that may result from insufficient or excessive sun exposure.

[0021] Furthermore, the invention aims to provide accurate and real-time guidance regarding sunscreen use by determining a safe sunlight exposure duration specific to the user.

[0022] Description of the Invention

[0023] The presence of tachysterol in the skin is an indirect and selective indicator that an optimal level of pre-D3 has been synthesised in the skin.

[0024] In this context, the invention provides a transparent, single-use guiding patch structure for sunlight exposure duration, impregnated with a biomarker that detects tachysterol in order to determine whether a sufficient amount of vitamin D has been synthesised in the skin.

[0025] The patch structure that is the subject of the registration is adhered to the surface of the skin and, in order to detect whether a sufficient amount of vitamin D has been synthesised in the user’s skin exposed to sunlight, changes colour upon reaching an adequate synthesis level, thereby informing the user. In this way, harmful skin damage resulting from excessive sun exposure is avoided, and the user is enabled to employsun protection methods and tools such as sunscreen, hats, sunglasses, UV-filtered clothing, and the like.

[0026] The duration of UV exposure required to ensure sufficient vitamin D synthesis in the skin varies from person to person depending on parameters such as season, time of exposure, exposed body surface area, and the individual’s Fitzpatrick skin type. At precisely this point, it is not possible to provide a general instruction such as “for everyone, at this location and during this time slot, exposure to sunlight for this duration is sufficient or appropriate for adequate vitamin D synthesis in the skin.” As a result of this problem encountered in the state of the art, the invention informs the user by changing colour through the detection of the presence of varying levels of tachysterol formed in the skin according to the user's location, season, time of sun exposure, exposed body surface area, and Fitzpatrick skin type, thereby enabling the user to take immediate action.

[0027] The invention utilises chromatography in order to detect the presence of tachysterol formed in the skin.

[0028] Chromatography is based on the principle of separating a component to be isolated by adding it to a stationary phase and separating it into its constituents by means of a mobile phase flowing over this stationary phase. A chromatographic system essentially consists of three components: a stationary phase, a mobile phase, and the mixture to be separated.

[0029] The patch structure subject to registration is configured in a manner that is flexible and does not damage the skin. Therefore, in a preferred embodiment of the invention, the paper chromatography technique is utilised, with filter paper used as the stationary phase.

[0030] Tachysterols formed in the skin are vitamin D derivatives and are generally lipophilic (fat-soluble). Accordingly, tachysterols dissolve in organic solvents such as ethanol, chloroform, benzene, and other non-polar or mildly polar solvents. For this reason, the invention employs non-polar or mildly polar solvents as the mobile phase. In a preferred embodiment of the invention, the aforementioned non-polar or mildly polar solvents are ethanol, chloroform, and benzene.In this context, the invention is a guiding patch structure for sunlight exposure duration, which detects whether a sufficient amount of vitamin D has been synthesised in the skin and informs the user by changing colour upon the level of tachysterol formed in the skin reaching a sufficient threshold, characterised by comprising:

[0031] • filter paper as the stationary phase by means of the paper chromatography technique, and

[0032] • non-polar or mildly polar solvents as the mobile phase on said filter paper. The invention is a single-use guiding patch structure for sunlight exposure duration, which determines that a sufficient amount of vitamin D has been synthesised in the skin by measuring precursors or vitamin D levels at the molecular level in human skin, informs the user of the optimal duration of sun exposure by changing colour upon reaching the appropriate level, and thereby minimises vitamin D deficiency or harmful skin damage that may result from insufficient or excessive sun exposure, comprising:

[0033] • An adhesive surface that adheres to the skin surface and has

[0034] o Filter paper as the stationary phase by means of the paper chromatography technique,

[0035] o Non-polar or mildly polar solvents as the mobile phase on said filter paper, and

[0036] • An outward-facing surface that informs the user by changing colour upon the level of tachysterol formed in the skin reaching a sufficient threshold, in order to detect whether a sufficient amount of vitamin D has been synthesised in the skin.

[0037] The implementation and operation of the invention are as follows:

[0038] - The user adheres the patch structure that is the subject of the registration to the area of the body surface that will be exposed to sunlight, immediately prior to sun exposure.

[0039] - As a result of ongoing UV exposure, pre-D3 in the skin is converted into inactive metabolites known as lumisterol and tachysterol.

[0040] - The presence of tachysterol formed in the skin causes a colour change on the patch structure adhered to the skin, by means of the solvents contained withinthe patch structure, which indicates that the amount of synthesised vitamin D has reached a sufficient level.

[0041] - In this case, the user understands that a sufficient amount of vitam in D has been synthesised in the skin and activates sun protection methods and tools such as sunscreen, hats, sunglasses, UV-filtered clothing, and the like.

[0042] Thus, the user is able to avoid harmful skin damage that may result from excessive sun exposure in real time.

[0043] In another embodiment of the invention, the presence of tachysterol formed in the skin is detected within the patch structure using high-performance liquid chromatography, and the user is notified.

[0044] Applicability to the Industry

[0045] The invention can be integrated into and used with any type of mobile device.

Claims

CLAIMS1. The invention is a single-use guiding patch structure for sunlight exposure duration, which determines that a sufficient amount of vitamin D has been synthesised in the skin by measuring precursors or vitamin D levels at the molecular level in human skin, informs the user of the optimal duration of sun exposure by changing colour upon reaching the appropriate level, and thereby minimises vitamin D deficiency or harmful skin damage that may result from insufficient or excessive sun exposure, comprising:• An adhesive surface that adheres to the skin surface and haso Filter paper as the stationary phase by means of the paper chromatography technique,o Non-polar or mildly polar solvents as the mobile phase on said filter paper, and• An outward-facing surface that informs the user by changing colour upon the level of tachysterol formed in the skin reaching a sufficient threshold, in order to detect whether a sufficient amount of vitamin D has been synthesised in the skin.

2. The guiding patch structure for sunlight exposure duration according to claim 1 , wherein the non-polar or mildly polar solvents are ethanol, chloroform, or benzene.